OUR FOCUS LEARN MORE Contact Us We design, conduct and analyse patient interviews in clinical trials following regulatory guidelines Slide

WHAT DOES CLINIGMA® OFFER?

At Clinigma®, we interview patients participating in clinical trials. Interviews can take place by phone or in person. These may be one-on-one interviews or focus groups. Our research is not limited to patients only and can include caregivers, family members and healthcare professionals.

100%
PATIENT-FOCUSED

Clinigma® is the only
company 100% focused on
patient interviews in
clinical trials.

GLOBAL
NETWORK

Clinigma® has the largest global
network of qualitative researchers
on the market.

SECURED
DATA

Clinigma® has a proprietary IT
portal for facilitating patient
interviews in clinical trials.

WHAT DOES CLINIGMA® OFFER?

At Clinigma®, we interview patients participating in clinical trials. Interviews can take place by phone or in person. These may be one-on-one interviews or focus groups. Our research is not limited to patients only and can include caregivers, family members and healthcare professionals.

100%
PATIENT-FOCUSED

Clinigma® is the only company 100% focused on patient interviews in clinical trials.

GLOBAL
NETWORK

Clinigma® has the largest global network of qualitative researchers on the market.

SECURED
DATA

Clinigma® has a proprietary IT portal for facilitating patient interviews in clinical trials.

INTERVIEWING PATIENTS
IN DIFFERENT SETTINGS

VE-Clinigma_Symbol - colour

Patient input to clinical trials

Gather patient and public input (PPI) to inform your drug development and allow patients and caregivers to have a say on what is relevant to measure in your planned clinical trials.

At Clinigma®, we develop interview guides considering comprehension, relevance, and completeness.

Our analysis focus on content validity and patient-tailoring of responses to determine clinically meaningful within-patient change in accordance with regulatory guidelines.

VE-Clinigma_Symbol - colour

Trial patient interviews

Get a clearer picture of your investigational drug by interviewing the patients in your clinical trials.

Interviewing patients enables you to capture insights directly from the medicine users and obtain valuable input to your drug development.

In addition, patient interviews can reveal insights that can be used as additional arguments for regulators’ approval of a drug as well as input to the discussion and design of future trials.

Patient interviews can be conducted at all stages and timepoints in a clinical trial – e.g. at entry, interim and/or exit.

VE-Clinigma_Symbol - colour

Feedback to trial patients

Keep your trial patients informed on the clinical trial results.

Patients participating in a clinical trial will often have a great interest in knowing the trial results and hearing how they performed in the trial.

The Clinigma® Portal facilitates easy communication between clinical sites, researchers and trial patients, making it easier to keep patients informed.

This is of high importance for patients to know how they have contributed to the clinical trial.

INTERVIEWING PATIENTS
IN DIFFERENT SETTINGS

VE-Clinigma_Symbol - colour

Trial patient interviews

Get a clearer picture of your investigational drug by interviewing the patients in your clinical trials.

Interviewing patients enables you to capture insights directly from the medicine users and obtain valuable input to your drug development.

In addition, patient interviews can reveal insights that can be used as additional arguments for regulators’ approval of a drug as well as input to the discussion and design of future trials.

Patient interviews can be conducted at all stages and timepoints in a clinical trial – e.g. at entry, interim and/or exit.

VE-Clinigma_Symbol - colour

Patient input to clinical trials

Gather patient and public input (PPI) to inform your drug development and allow patients and caregivers to have a say on what is relevant to measure in your planned clinical trials.

At Clinigma®, we develop interview guides considering comprehension, relevance, and completeness.

Our analysis focus on content validity and patient-tailoring of responses to determine clinically meaningful within-patient change in accordance with regulatory guidelines.

VE-Clinigma_Symbol - colour

Feedback to trial patients

Keep your trial patients informed on the clinical trial results.

Patients participating in a clinical trial will often have a great interest in knowing the trial results and hearing how they performed in the trial.

The Clinigma® Portal facilitates easy communication between clinical sites, researchers and trial patients, making it easier to keep patients informed.

This is of high importance for patients to know how they have contributed to the clinical trial.

UNDERSTANDING

AND PRESENTING DATA

Once patient-experience data has been collected, Clinigma® can help clients to communicate the statistical results and qualitative insights in a format that meets the needs of internal and external stakeholders. This includes manuscripts for peer-reviewed publications, materials formatted to meet the requirements of a regulatory agency and written reports or slide-decks to brief internal stakeholders.

COMPLIANCE AND PRIVACY

Clinigma® respects the rights of the people we interview to have their information
protected and their safety and anonymity safeguarded from harmful practices.